Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis.

BMJ : British Medical Journal
George KrasopoulosMichael R Buchanan

Abstract

To determine if there is a relation between aspirin "resistance" and clinical outcomes in patients with cardiovascular disease. Systematic review and meta-analysis. Electronic literature search without language restrictions of four databases and hand search of bibliographies for other relevant articles. Inclusion criteria included a test for platelet responsiveness and clinical outcomes. Aspirin resistance was assessed, using a variety of platelet function assays. 20 studies totalling 2930 patients with cardiovascular disease were identified. Most studies used aspirin regimens, ranging from 75-325 mg daily, and six studies included adjunct antiplatelet therapy. Compliance was confirmed directly in 14 studies and by telephone or interviews in three. Information was insufficient to assess compliance in three studies. Overall, 810 patients (28%) were classified as aspirin resistant. A cardiovascular related event occurred in 41% of patients (odds ratio 3.85, 95% confidence interval 3.08 to 4.80), death in 5.7% (5.99, 2.28 to 15.72), and an acute coronary syndrome in 39.4% (4.06, 2.96 to 5.56). Aspirin resistant patients did not benefit from other antiplatelet treatment. Patients who are resistant to aspirin are at a greater risk o...Continue Reading

Associated Clinical Trials

Apr 29, 2019·Jose Luis Mendez

References

Dec 1, 1994·Stroke; a Journal of Cerebral Circulation·C M HelgasonL D Brace
Mar 1, 1993·Stroke; a Journal of Cerebral Circulation·C M HelgasonL D Brace
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 4, 2000·Stroke; a Journal of Cerebral Circulation·T KawasakiJ Kambayashi
Feb 27, 2001·Statistics in Medicine·P MacaskillL Irwig
Aug 13, 2003·Journal of Thrombosis and Haemostasis : JTH·C Patrono
Mar 19, 2004·Journal of the American College of Cardiology·Martin J QuinnEric J Topol
Sep 24, 2004·Circulation·Charles H HennekensGarret A FitzGerald
Sep 25, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Marco Cattaneo
Jul 2, 2005·The American Journal of Medicine·Pui-Yin LeeChu-Pak Lau
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Feb 18, 2006·The Canadian Journal of Cardiology·Michael R Buchanan
Jan 24, 2007·American Heart Journal·Marcel M C HovensMenno V Huisman

❮ Previous
Next ❯

Citations

Jan 6, 2010·Annals of Hematology·Birgit LinnemannEdelgard Lindhoff-Last
Apr 22, 2011·Journal of Neurology·Serkan OzbenTomris Ozben
Nov 13, 2012·Wiener medizinische Wochenschrift·Matthias K FreynhoferKurt Huber
Jun 23, 2009·Journal of Thrombosis and Thrombolysis·Nabeel AhmedGraham J Davies
May 15, 2010·Journal of Thrombosis and Thrombolysis·Martin Moser, Christoph Bode
May 27, 2010·Journal of Thrombosis and Thrombolysis·Kiran Kumar R MangalpallySasidhar Guthikonda
May 27, 2011·Journal of Thrombosis and Thrombolysis·David VivasAntonio Fernández-Ortiz
Jul 27, 2010·International Urology and Nephrology·Abdallah Sassine GearaSuzanne El-Sayegh
Jun 21, 2012·International Urology and Nephrology·Kadriye Orta KilickesmezTevfik Gurmen
Jun 18, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Li LiuYu Long
Jun 8, 2011·Journal of General Internal Medicine·Scot H SimpsonThane Chambers
Dec 17, 2008·Chinese Journal of Integrative Medicine·Hong-cai SHANGMike J Clarke
Jul 9, 2008·Current Atherosclerosis Reports·Girish R MoodDeepak L Bhatt
Feb 21, 2009·Current Atherosclerosis Reports·Gilead I LancasterHitender Jain
Jan 15, 2009·Current Treatment Options in Cardiovascular Medicine·Paul A Gurbel, Udaya S Tantry
Feb 14, 2013·Journal of Cardiovascular Translational Research·Fabiana RolliniDominick J Angiolillo
Apr 17, 2013·Molecular Diagnosis & Therapy·Athanasios Karathanos, Tobias Geisler
Dec 9, 2008·American Heart Journal·Muthiah VaduganathanEli I Lev
May 2, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Norbert ZimmermannThomas Hohlfeld
May 15, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert C BlockS Georas
Feb 2, 2010·Nature Reviews. Drug Discovery·Alan D Michelson
Dec 2, 2009·European Heart Journal·Dominick J AngiolilloShinya Goto
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Gabriella PuschLaszlo Szapary
Jul 10, 2009·Current Opinion in Hematology·Galia Spectre, David Varon
Feb 19, 2009·International Journal of Clinical Practice·J B LiL Huang
Jan 19, 2008·BMJ : British Medical Journal·Giuseppe Biondi-Zoccai, Marzia Lotrionte
Feb 9, 2008·BMJ : British Medical Journal·Peter Elwood, Gareth Morgan
Aug 27, 2011·International Journal of Endocrinology·Nicholaos KakourosJon R Resar
Jun 16, 2011·Cephalalgia : an International Journal of Headache·Tobias KurthJulie E Buring
Oct 18, 2011·Vascular Medicine·Emil M DegomaEmile R Mohler
Mar 19, 2013·BMC Medical Research Methodology·Tobias van den BergHenrica C W de Vet
Sep 2, 2008·Journal of Translational Medicine·Kenneth A SchwartzAnthony C De Franco
Sep 2, 2008·Journal of Translational Medicine·Eduard Shantsila, Gregory Y H Lip
Jan 8, 2011·Anesthesia and Analgesia·Richard Hall, C David Mazer
Apr 23, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomoyuki IkedaHisanori Horiuchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.